MedTrace Logo

Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome

NCT01104610 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-07-13

No results posted yet for this study

Summary

The purpose of this study is to investigate the evolution of daytime partial pressure of carbon dioxide in the blood (PaCO2) after 6 weeks of noninvasive ventilation-pressure support ventilation (NIV-PSV) with target volume versus continuous positive airway pressure (CPAP) alone versus NIV-PSV.

Conditions

  • Obesity Hypoventilation Syndrome

Interventions

DEVICE

Breas Vivo 40

The Vivo 40 will be used either in CPAP mode, PSV mode without Target Volume or PSV mode with Target Volume

Sponsors & Collaborators

  • Breas Medical S.A.R.L.

    lead INDUSTRY

Principal Investigators

  • Jean-Louis Pepin, prof · University Hospital, Grenoble

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01104610 on ClinicalTrials.gov